Dec. 2, 2022 – , which published Phase 1 results of a small clinical trial for a vaccine technology that aims to cause the body to create a rare kind of cell.
There is no cure for HIV, but there are treatments to manage how the disease progresses. HIV attacks the body’s immune system, destroys white blood cells, and increases susceptibility to other infections, AAAS summarized. More than 1 million people in the U.S. and 38 million people worldwide have HIV.
Study authors said this is just the first step in the multiphase vaccine design, which so far is a theory. Further study is needed to see if the next steps also work in humans and, then, if all the steps can be linked together, and can be effective against HIV.: “Vaccination induces HIV broadly neutralizing antibody precursors in humans,” “Triggering rare HIV antibodies by vaccination.”